Test Updates


Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.


Test UpdateDate

Hawaii DOH Medical Advisory: Update #7 - Coronavirus Disease 2019 (COVID-19)

Updated information on private laboratory testing for SARS-CoV-2 (COVID-19), including priorities for testing


SARS-CoV-2 (COVID-19) New Test Update as of Tuesday, March 17, 2020 with Collection Instructions

Effective March 10, 2020, Clinical Labs of Hawaii began offering testing for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).


United Healthcare Insurance March 1, 2020 Billing Update

Beginning March 1, 2020, United Healthcare Insurance will require prior authorization/notification for genetic and molecular testing performed in an outpatient setting.


Respiratory Panel by PCR

CLH offers the FilmArray Respiratory Panel from BioFire Diagnostics for the detection of 17 respiratory viruses and 3 bacteria from a single specimen. This panel does NOT test for the SARS-CoV-2 virus.


Biotin Interference Test Update

Biotin administration (especially in high doses) may impact common, immunoassay-based, laboratory tests.


Human Papillomavirus (HPV) New Methodology and Algorithm

CLH/PPPL will be performing Human Papillomavirus (HPV) testing locally on Oahu using the Aptima nucleic acid amplification assay.


Rapid HIV-1/2 Antigen/Antibody Combo Test Update

Clinical Labs of Hawaii is pleased to offer the Rapid Alere Determine™ HIV-1/2 Ag/Ab Combo qualitative immunoassay for the simultaneous detection of HIV-1 p24 antigen and antibodies to HIV-1 and HIV2.


Chlamydia and Gonorrhea Test Update

Test codes for CT-GC testing by Transcription Mediated Amplification (TMA) have been updated.


QuantiFERON-TB Gold Plus

Clinical Labs of Hawaii is please to announce the introduction of the QuantiFERON-TB Gold Plus (QFT-Plus) assay, which offers optimized analyses with tuberculosis (TB)-specific antigens that elict both CD4+ and CD8+ T-cell responses.


NT-proBNP Update

Effective January 30, 2019 Clinical Labs of Hawaii will offer in-house testing for N-terminal pro B-type Natriuretic Peptide (NT-proBNP) as a replacement for current BNP testing.


High Sensitivity Cardiac Troponin T

Effective January 30, 2019, Clinical Labs will offer in-house testing for High Sensitivity Cardiac Troponin T (cTnT GEN 5) as a replacement for current Troponin I testing.


Immunoassay Reference Range Update

Effective January 30, 2019, Clinical Labs of Hawaii will be implementing the Roche Diagnostic Cobas® System of immunoassay analyzers. Please read bulletin for important reference range updates.